Heart scan study aims to predict sudden death before it strikes
NCT ID NCT00181233
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing whether advanced MRI and CT scans can identify people at highest risk for sudden cardiac death. Researchers will follow 400 participants who have low heart function and are scheduled to receive an implantable defibrillator. The goal is to see if these imaging techniques can better predict who will experience a life-threatening heart event.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to better ways to predict who is at highest risk for sudden cardiac death, helping doctors decide who needs a defibrillator.
- What could go wrong
- This is an observational study, not a treatment trial. The imaging techniques may not prove accurate enough to change current practice, and results may take years to confirm.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 400 people
The number the study aims to enrol. It can still change while the study runs.
- Start date
-
Oct 2003
- Expected to finish
-
Jul 2029
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients with contractile dysfunction (EF\< or = 35%) on an ischemic or non-ischemic basis undergoing clinically-indicated ICD implantation for primary prevention of sudden cardiac death (SCD)
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Left ventricular ejection fraction \<or = 35% * Planned implantable cardioverter-defibrillator (ICD) implantation for clinical indications (primary prevention) Exclusion Criteria: * History of sudden death (secondary prevention) * Contraindication to undergoing MRI (metallic implant, pacemaker, etc.)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Sudden cardiac death are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Johns Hopkins Medical Institutions
RECRUITINGBaltimore, Maryland, 21287, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can genes explain sudden cardiac death in young athletes?
- Can we predict sudden cardiac arrest in heart disease patients?
- Shock therapy: can a heart device save lives in rare angina?
- Tiny heart monitor could uncover why dialysis patients die suddenly
- Heart disease detective: 1,000-Person study hunts for hidden genetic triggers of sudden cardiac death
- AI could prevent sudden cardiac death in young athletes